Current Concepts in the Treatment of Aneurysmal Bone Cysts

High-Yield Summary

• Aneurysmal Bone Cysts (ABCs) are benign, expansile, osteolytic lesions characterized by blood-filled spaces separated by septa, predominantly affecting patients under 20 years old.
• Surgical intervention is indicated for symptomatic lesions, risk of pathological fracture, or progressive growth; curettage with adjuvant therapy remains the mainstay.
• Accurate diagnosis requires differentiation from telangiectatic osteosarcoma and other cystic bone lesions via imaging and biopsy.
• Recurrence rates after curettage alone can be high; adjuncts such as high-speed burring, phenol, or cryotherapy reduce recurrence.
• Emerging minimally invasive techniques, including percutaneous sclerotherapy and selective arterial embolization, offer alternatives in select cases.

Clinical Fundamentals

Aneurysmal Bone Cysts are expansile, osteolytic lesions primarily involving the metaphysis of long bones and posterior elements of the spine. The lesion consists of blood-filled cavities separated by fibrous septa containing osteoclast-like giant cells and reactive woven bone. Biomechanically, ABCs weaken the structural integrity of bone, predisposing to pathological fractures and deformity, especially in weight-bearing bones.

Epidemiologically, ABCs account for approximately 1–2% of primary bone tumors, with a peak incidence in the first two decades of life. The lesion may arise de novo (primary ABC) or secondarily within other bone tumors, such as giant cell tumor or chondroblastoma. The rapid growth phase and expansile nature necessitate timely intervention to prevent complications.

Classification & Diagnosis

Diagnostic Pearls:

• Imaging: MRI is critical, showing characteristic fluid-fluid levels within cystic spaces; CT defines cortical integrity and matrix mineralization.
• Biopsy: Essential to exclude telangiectatic osteosarcoma, which mimics ABC radiographically but requires oncologic resection.
• Pitfall: Misdiagnosis can lead to inappropriate treatment; always correlate clinical, radiologic, and histologic data.

Decision-Making Algorithm

Non-operative management is reserved for asymptomatic, stable lesions without cortical compromise or risk of fracture, typically involving observation and serial imaging.

Operative management is indicated when:

• The lesion causes pain, swelling, or neurological symptoms (especially spinal ABCs).
• There is cortical thinning with impending or actual pathological fracture.
• The lesion demonstrates progressive growth on serial imaging.

Surgical Approach Selection:

• Curettage with adjuvant therapy is preferred for accessible lesions in appendicular skeleton.
• En bloc resection is reserved for recurrent or aggressive lesions where curettage is insufficient.
• Minimally invasive techniques such as percutaneous sclerotherapy or embolization are considered for lesions in anatomically challenging locations or poor surgical candidates.

Implant choice depends on defect size and location; structural grafting or internal fixation may be necessary to restore mechanical stability.

Surgical Mastery & Pearls

Stepwise Surgical Technique for Curettage of ABC:

1. Exposure: Achieve wide exposure to allow thorough visualization of the cyst cavity.
2. Cortical Window Creation: Create a sufficiently large cortical window to access all cystic spaces.
3. Curettage: Aggressively remove all cyst lining and septa using curettes and high-speed burr.
4. Adjuvant Application: Apply phenol, liquid nitrogen, or argon beam coagulation to the cavity walls to eradicate residual microscopic disease.
5. Defect Management: Fill the cavity with autograft, allograft, or bone substitute; consider internal fixation if structural integrity is compromised.

Intraoperative Red Flags:

• Excessive bleeding from cyst cavity—prepare for hemostasis with electrocautery and topical agents.
• Failure to identify all septations—may lead to incomplete curettage and recurrence.
• Cortical breach with soft tissue extension—consider wider resection margins.

Technical Tips:

• Use intraoperative fluoroscopy to confirm complete lesion clearance.
• Maintain meticulous hemostasis to improve visualization.
• Preserve surrounding neurovascular structures, especially in spinal or pelvic lesions.

Evidence-Based Synthesis

Recent literature emphasizes the balance between aggressive local control and preservation of function. Curettage with adjuvant therapy remains the gold standard, with recurrence rates reduced from approximately 30% to under 10% when adjuvants are used. A randomized controlled trial comparing phenol versus cryotherapy showed no significant difference in recurrence but highlighted cryotherapy’s higher complication rate.

Percutaneous sclerotherapy with doxycycline or polidocanol has gained traction, particularly for lesions in the pelvis and spine, demonstrating comparable control with fewer complications in retrospective series. However, prospective data remain limited, and long-term outcomes are under investigation.

Selective arterial embolization is effective as a primary or adjunctive treatment, especially for spinal ABCs, reducing intraoperative blood loss and lesion size. The literature reveals ongoing debate regarding the optimal timing and combination of embolization with surgery.

The heterogeneity of ABC presentations and lesion locations necessitates individualized treatment plans. Current consensus favors a multidisciplinary approach integrating surgical, interventional radiology, and medical therapies.

Master Class Pro-Tip

Mastery in ABC treatment hinges on anticipating lesion behavior beyond imaging. Intraoperative assessment of cyst septations and cortical integrity guides the extent of curettage and adjuvant use. Employing a staged approach—initial embolization to reduce vascularity followed by meticulous curettage with adjuvants—minimizes recurrence and morbidity. Cultivate a low threshold for adjunctive therapies in lesions with soft tissue extension or prior recurrence, and always tailor reconstruction to restore biomechanical stability without compromising future growth in pediatric patients.

Last Updated on March 13, 2026 by OrthoNet AI